2025
SJR Q1
JCR Q1 · 3,7
30 matched articles
SCIE
Journal detail
Pediatric Drugs
- Country
- Switzerland · Western Europe
- Type
- journal
- ISSN
-
1174587811792019
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,224
- Quartile Q1
- H-Index 77
- Cites/doc 4,19
- Docs (3y) 171
- Cites (3y) 717
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 3,7
- 5Y JIF 3,8
- JCI 1,03
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,224 | 3,7 | 3,8 | 1,03 | Q1 | 77 |
| 2024 | Q1 | Q1 | 0,969 | 3,3 | 3,8 | 1,08 | Q1 | 72 |
| 2023 | Q1 | Q1 | 1,017 | 3,4 | 3,4 | 1,03 | Q1 | 72 |
| 2022 | Q1 | Q1 | 0,818 | 3,7 | 3,4 | 1 | Q1 | 72 |
| 2021 | Q2 | Q1 | 0,709 | 4 | 3,3 | 0,87 | Q2 | 72 |
| 2020 | Q2 | Q2 | 0,75 | 3 | 2,8 | 0,89 | Q2 | 72 |
| 2019 | Q2 | Q2 | 0,685 | 2,5 | 2,3 | 0,81 | Q2 | 72 |
| 2018 | — | Q2 | — | 1,8 | 2,2 | 0,77 | Q2 | — |
| 2017 | Q2 | Q2 | 0,814 | 2 | 2,2 | 0,81 | Q2 | 72 |
| 2016 | Q1 | Q2 | 0,986 | 2,1 | 2,2 | — | — | 72 |
| 2015 | Q1 | Q2 | 0,855 | 2,1 | 1,9 | — | — | 72 |
| 2014 | Q2 | Q2 | 0,777 | 2 | 1,9 | — | — | 72 |
| 2013 | Q2 | Q2 | 0,682 | 1,7 | 1,8 | — | — | 72 |
| 2012 | Q2 | Q2 | 0,621 | 1,9 | 1,9 | — | — | 72 |
| 2011 | Q2 | Q2 | 0,675 | 1,8 | 1,9 | — | — | 72 |
| 2010 | Q2 | — | 0,566 | — | — | — | — | 72 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PEDIATRICS | SCIE | Q1 | Q1 | 16/190 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 120/356 |
| 2024 | PEDIATRICS | SCIE | Q1 | Q1 | 21/191 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 122/352 |
| 2023 | PEDIATRICS | SCIE | Q1 | Q1 | 19/186 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 105/354 |
| 2022 | PEDIATRICS | SCIE | Q1 | Q1 | 22/130 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 111/278 |
| 2021 | PEDIATRICS | SCIE | Q1 | Q2 | 25/130 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 116/279 |
| 2020 | PEDIATRICS | SCIE | Q2 | Q2 | 38/129 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 165/276 |
| 2019 | PEDIATRICS | SCIE | Q2 | Q2 | 34/128 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 153/271 |
| 2018 | PEDIATRICS | SCIE | Q2 | Q2 | 59/125 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 199/267 |
| 2017 | PEDIATRICS | SCIE | Q2 | Q2 | 51/124 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 173/261 |
| 2016 | PEDIATRICS | SCIE | Q2 | — | 41/121 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 154/257 |
| 2015 | PEDIATRICS | SCIE | Q2 | — | 38/120 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 149/255 |
| 2014 | PEDIATRICS | SCIE | Q2 | — | 40/120 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 151/255 |
| 2013 | PEDIATRICS | SCIE | Q2 | — | 48/118 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 166/256 |
| 2012 | PEDIATRICS | SCIE | Q2 | — | 43/122 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 162/261 |
| 2011 | PEDIATRICS | SCIE | Q2 | — | 41/115 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 160/261 |